LOUISA ASIAMAH: Open Payments
NPI 1790476968 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,824 in 116 payments from 27 companies in 2025. Trend: 2023 $323 · 2024 $3,450 · 2025 $2,824
Food & beverage: $2,824
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $462 |
| Lilly USA, LLC | 16 | $412 |
| AstraZeneca Pharmaceuticals LP | 9 | $248 |
| ABBVIE INC. | 9 | $215 |
| Neurocrine BioSciences, Inc. | 7 | $184 |
| Otsuka America Pharmaceutical, Inc. | 9 | $148 |
| Biogen, Inc. | 7 | $139 |
| Exact Sciences Corporation | 6 | $136 |
| Gilead Sciences, Inc. | 5 | $135 |
| Ardelyx, Inc. | 4 | $91 |
Products named: AUSTEDO XR, MOUNJARO, INGREZZA, VRAYLAR, REXULTI, LEQEMBI, Cologuard Collection Kit, UZEDY.
Industry payments across MA — which companies pay providers there.
